The Efficacy of Denosumab in Decreasing Periprosthetic Bone Loss in Patients With Total Knee Arthroplasty
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of Denosumab in decreasing the periprosthetic bone resorption
after Total Knee Arthroplasty compared to placebo in 60 patients (30 placebo and 30
Denosumab) within a year after surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau